Cough Remedies Market is Anticipated to Register US$ 9.91 Bn by 2030

PORTLAND, OREGON, UNITED STATE, March 26, 2022 /EINPresswire.com/ — According to the report published by Allied Market Research, the global Cough Remedies Market generated $7.08 billion in 2020, and is anticipated to reach $9.91 billion by 2030, manifesting a CAGR of 3.4% from 2021 to 2030. The study offers an in-depth analysis of the market size, current trends, and future estimations.

For Right Perspective and Competitive Insights, Get Sample Report at:

Rise in geriatric population, surge in vehicle pollution, increase in demand for over-the-counter medicines, rise in R&D activities, and surge in awareness about medicines are expected to help the cough remedies market generate more revenue in the coming years. In addition, rise in a number of testing and research facilities especially in the field of biotechnology and pharmaceutical companies adds to the significant market growth.

On the other hand, strict regulations concerning the efficiency of cough remedies hinder the market growth. Contrarily, rise in incidences of conditions attacking the respiratory system opens doors of opportunities for the growth of the market in coming years.

Leading players of the global cough remedies market analyzed in the research include Astrazeneca PLC (Astrazeneca), GlaxoSmithKline PLC, Prestige Brands, Inc., Reckitt Benckiser Group PLC., Bayer Ag, Novartis AG, Procter & Gamble, Johnson & Johnson, Pfizer, Inc., and Sun Pharmaceuticals Industries Limited.

Covid-19 impact on global cough remedies market:
• Increase in strict government rules regarding lockdowns led to reduced growth of the market.
• Introducing new products that can help fight the advent of the COVID-19 virus boosted the market.
• There has been a growth in research activities to treat cough caused by the virus, which is anticipated to boost the growth of the global cough remedies market in the post-Covid world.
• The report segments the global cough remedies market on the basis of product type, age group, distribution channel, and region.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert:

Based on product type, the bronchodilators and cough suppressants segment accounted for the largest market share in 2020, contributing to more than half of the total share, and is expected to maintain the lead throughout the forecast period. On the other hand, the antibiotics segment is estimated to witness the fastest CAGR of 3.9% from 2021 to 2030.

Based on region, Asia-Pacific contributed to the highest share in 2020, followed by Europe and North America, holding nearly two-fifths of the total share and is expected to maintain dominance throughout the forecast period. On the other hand, LAMEA is expected to portray the fastest CAGR of 4.5% during the forecast period.

Based on the distribution channel, the retail pharmacy segment contributed to the largest share in 2020, accounting for more than two-thirds of the global cough remedies market. The same segment is expected to lead throughout the forecast period. However, the online pharmacy segment is expected to manifest the highest CAGR of 6.1% from 2021 to 2030.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial:

Get News and Press Released Update, Follow us @
Web:
LinkedIn:

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn